Navigation Links
Inverseon's Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet
Date:1/14/2009

SAN FRANCISCO, Jan. 14 /PRNewswire/ -- Inverseon, Inc. (http://www.inverseon.com) announces the receipt of a notice of allowance from the United States Patent Office covering its oral product INV102 for asthma. Additionally, a comment highlighting Inverseon's clinical asthma study was published in the January 10, 2009 issue of The Lancet.

"To our knowledge, this would be the first patent for the utilization of certain beta blockers for the treatment of asthma," commented Amie E. Franklin, PhD, of Inverseon. "A similar story played out 10 years ago in congestive heart failure where certain beta blocker drugs have become billion dollar products."

"The Lancet Comment on Inverseon's human asthma study combined with the notice of allowance from the US Patent Office represent important external validation of Inverseon's approach to asthma. We believe that our oral therapy has the potential to be a significant product," commented William J. Garner, MD, Chairman of Inverseon.

About Inverseon, Inc.

Inverseon's product development programs target significant unmet medical needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hypertension. Inverseon was founded based on the original work of Prof. Richard Bond of the University of Houston. Professor Bond termed the effects "Paradoxical Pharmacology," based on the divergence of acute versus chronic effects of certain drugs in chronic diseases. For further information, please visit Inverseon's website at http://www.inverseon.com.

Forward-Looking Statement

This press release may contain forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "beli
'/>"/>

SOURCE Inverseon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
2. Visualizing asthma-causing immune cells at work
3. New consensus on work-related asthma
4. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
5. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
6. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
7. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
8. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
9. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
10. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
11. Drug Reduces Airway Mucus in Preclinical Asthma Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... London, UK (PRWEB) March 27, 2015 ... on the back of the recession and high prices ... the market has recovered and keeps on gaining momentum ... of NPK stands at more than 100,000 thousand tonnes. ... post-crisis years. Meantime, the global capacity rocketed during 2012-2013, ...
(Date:3/27/2015)...  Peter Walter was chosen as winner of the ... on how proteins are transported between cellular compartments and ... cells use to handle stress tied to the aggregation ... biochemistry at the University of California, San Francisco. His ... human diseases related to defective protein folding and transport. ...
(Date:3/27/2015)... 2015 Governor Andrew M. Cuomo today ... 43North - the world’s largest business idea competition with ... of $1 million, six $500,000 awards and four $250,000 ... to compete for prizes that will turn ideas with ... New York region. , "Last year's successful 43North ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The Market ... formed a strategic alliance with Designing Gig LLC to ... clients. , “Forging this alliance with Designing ... Now we can extend a comprehensive, end-to-end, digital solution ... strategy, and execution,” said Chuck Miller, president of The ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2
... backdrop of a flagging,economy, bailouts, and bleak predictions, ... a future as bright as New Year,s Eve ... the Embozene(TM),Color-Advanced Microspheres embolization platform for the treatment ... blood vessels in many,locations) and arteriovenous malformations (defects ...
... Calif., Dec. 31 Nektar Therapeutics,(Nasdaq: ... closed the divestiture,of specific Nektar pulmonary delivery assets, ... in cash. The transaction was completed,on December 31, ... closing, Novartis assumes ownership of certain dry powder ...
... & Drug,Administration (FDA) today approved a new nucleic acid test ... hepatitis C RNA and hepatitis B,DNA in a single, automated ... on the cobas s 201 system, is a qualitative in ... HIV-1 Group O RNA,HIV-2 RNA, hepatitis C Virus RNA and ...
Cached Biology Technology:First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 2First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 3First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 4Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million 2FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 2FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 3
(Date:3/11/2015)... March 11, 2015   The Sync Project™ ... to scientifically measure and harness music to improve ... biometrics and objective measurements of physiology, enabling the ... scale in large populations. It is designed for ... clinicians perform rigorous studies and accelerate the discovery ...
(Date:3/10/2015)... 2015   Tute Genomics , pioneer in affordable, ... next-generation sequencing company PrimBio Research Institute to ... gene panel interpretation. PrimBio, a certified Life ... current technologies to support the work of experts on ... two types of exome sequencing services: 1) Targeted Exome ...
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3
... BOSTON -- David Mooney, Ph.D., a core faculty member at ... and the Robert P. Pinkas Family Professor of Bioengineering at ... elected to the Institute of Medicine (IOM) of the National ... field of medicine in the United States. The IOM ...
... tons of crushing force and volcanic heat to forge ... a way to cheaply make nanodiamonds on a lab ... The nanodiamonds are formed directly from a gas and ... holds promise for many uses in technology and industry, ...
... is available in German . ... the European region preliminary round of the international iGEM competition. The ... has developed to generate energy directly from bacteria that they judged ... dreamed that we would win, says Lukas Rositzka, a member of ...
Cached Biology News:Wyss Institute core faculty member elected to the Institute of Medicine of the National Academies 2CWRU makes nanodiamonds in ambient conditions 2CWRU makes nanodiamonds in ambient conditions 3CWRU makes nanodiamonds in ambient conditions 4Bielefeld iGEM team wins European preliminary round 2
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...
Chlamydia pneumoniae (TWAR)...
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
Biology Products: